Byoung Chul Cho
MD, PhD
Professor of Internal Medicine and Oncology
👥Biography 个人简介
Byoung Chul Cho is a world-renowned clinical investigator specializing in EGFR-driven NSCLC and novel bispecific antibody therapies. He led pivotal MARIPOSA and PAPILLON trials evaluating amivantamab plus lazertinib and amivantamab plus chemotherapy in EGFR-mutant NSCLC, establishing new standards of care. His research program at Yonsei Cancer Center has generated landmark datasets informing global treatment guidelines. He is a highly cited author in the field of targeted thoracic oncology.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Byoung Chul Cho 的研究动态
Follow Byoung Chul Cho's research updates
留下邮箱，当我们发布与 Byoung Chul Cho（Yonsei Cancer Center, Yonsei University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment